We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Series of preclinical studies demonstrate the therapeutic potential of PAT-DX1, a first-in-class, synthetically lethal DNA-binding antibody in primary brain cancers and brain metastases. Patrys...
PAT-SM6 clinical trial data from all 4 cohorts to be presented at prestigious American Society of Hematology conference From 11 currently evaluable patients, 4 (36%) experienced stable...
Commencement of GMP Production Project for Lead Anti-Cancer Product PAT-LM1 - Laureate Biopharmaceutical Services to manufacture lead product PAT-LM1 Appointment follows Laureate exceeding yield...
NEW YORK, May 24 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R)) today began trading Citigroup Funding Inc.'s PACERS Linked to eBay Inc. Priced at $10.00 per unit with an initial offer...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.003 | 0.004 | 0.003 | 1071380 | 0.00314422 | DE |
4 | -0.0015 | -33.3333333333 | 0.0045 | 0.0045 | 0.003 | 1658325 | 0.00360919 | DE |
12 | 0 | 0 | 0.003 | 0.005 | 0.003 | 2273443 | 0.00367411 | DE |
26 | -0.004 | -57.1428571429 | 0.007 | 0.0075 | 0.003 | 1807297 | 0.00415084 | DE |
52 | -0.005 | -62.5 | 0.008 | 0.01 | 0.003 | 1418847 | 0.00596197 | DE |
156 | -0.037 | -92.5 | 0.04 | 0.045 | 0.003 | 2305048 | 0.01952151 | DE |
260 | -0.016 | -84.2105263158 | 0.019 | 0.063 | 0.003 | 4368504 | 0.02933837 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions